Home > Journals > Chirurgia > Past Issues > Chirurgia 2020 August;33(4) > Chirurgia 2020 August;33(4):200-5

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

ORIGINAL ARTICLE   

Chirurgia 2020 August;33(4):200-5

DOI: 10.23736/S0394-9508.19.05057-5

Copyright © 2019 EDIZIONI MINERVA MEDICA

language: English

Lung resections in patients with multi-drug-resistant TB: rationale and outcome. Lessons from St. Petersbourg, Russian Federation

Flavio COLAUT 1 , Grigorii BOYARKIN 2, Taufik BASEK 2, Lyberis PARASKEVAS 3, Marco MASSANI 1, Aurelio PIAZZA 1, Alexey ELKIN 2

1 Unit of General and Thoracic Surgery, Ca’ Foncello Main City Hospital, Treviso, Italy; 2 Unit of Thoracic Surgery, North-West State Medical University by I.I. Mechnikov, St. Petersbourg, Russian Federation; 3 Unit of Thoracic Surgery, University of Turin, Turin, Italy



BACKGROUND: Drug resistant and multidrug resistant cases of TB represent a new challenge for the next future, particularly if we consider the great migrations of people across Europe that occur nowadays.
METHODS: Lung resections has been reconsidered to treat these cases, with the main aim to protect the community from spreading of infection. This means that surgery reveals to be very useful to treat patients, both for curative both for palliative therapy. Moreover, we have to remember that thoracic surgery was born as surgery for patient affected by TB.
RESULTS: In the Russian Federation, where these cases are endemic and very numerous, lung resections for complicated TB has been performed systematically since 2014 and data show that epidemiological control of the disease has been reached. In this paper we present the surgical experience of University Hospital of St Petersbourg.
CONCLUSIONS: Lung resections for patient with complicated TB seem to be very important in the next future, not only to treat patients, but also to ameliorate the aknowledgment of TB, lung cancer and HIV, since these pathological entities reveal quite similar risk factors.


KEY WORDS: Tuberculosis, multidrug-resistant; Lung; Epidemiology

top of page